Milestone Scientific Inc. (NYSE:MLSS) Director Sells $15,600.00 in Stock

by · The Markets Daily

Milestone Scientific Inc. (NYSE:MLSS – Get Free Report) Director Michael Mcgeehan sold 20,000 shares of the company’s stock in a transaction dated Thursday, December 19th. The stock was sold at an average price of $0.78, for a total transaction of $15,600.00. Following the completion of the sale, the director now directly owns 575,273 shares in the company, valued at $448,712.94. This represents a 3.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Michael Mcgeehan also recently made the following trade(s):

  • On Tuesday, September 24th, Michael Mcgeehan sold 209 shares of Milestone Scientific stock. The shares were sold at an average price of $1.00, for a total transaction of $209.00.

Milestone Scientific Stock Performance

Shares of NYSE MLSS opened at $0.93 on Friday. The company has a market cap of $72.05 million, a PE ratio of -13.21 and a beta of 1.10. The firm’s 50 day moving average price is $0.81 and its 200-day moving average price is $0.86. Milestone Scientific Inc. has a 52-week low of $0.52 and a 52-week high of $1.10.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on MLSS. StockNews.com assumed coverage on Milestone Scientific in a research note on Friday. They issued a “hold” rating on the stock. Benchmark restated a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.

Get Our Latest Research Report on MLSS

Institutional Trading of Milestone Scientific

Institutional investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC grew its stake in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in Milestone Scientific in the third quarter worth approximately $48,000. Finally, World Investment Advisors LLC bought a new stake in Milestone Scientific in the 3rd quarter worth approximately $91,000. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

About Milestone Scientific

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

Further Reading